Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sucampo Pharma Inc (SCMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 476,215
  • Shares Outstanding, K 46,460
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • 36-Month Beta 1.45
  • Price/Sales 2.12
  • Price/Cash Flow 4.36
  • Price/Book 2.80

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.65 +6.22%
on 05/03/17
10.95 -6.39%
on 05/15/17
+0.35 (+3.54%)
since 04/26/17
3-Month
9.30 +10.22%
on 04/18/17
12.75 -19.61%
on 03/08/17
-1.50 (-12.77%)
since 02/24/17
52-Week
9.30 +10.22%
on 04/18/17
17.55 -41.60%
on 11/30/16
-1.50 (-12.77%)
since 05/26/16

Most Recent Stories

More News
Sucampo Pharmaceuticals Shares Down 21.8% Since SmarTrend's Sell Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 5 months, Sucampo Pharmaceuticals has returned 21.77% as of today's recent...

SCMP : 10.25 (-2.38%)
Sucampo Pharmaceuticals Has Returned 26.8% Since SmarTrend Recommendation (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 5 months, Sucampo Pharmaceuticals has returned 26.82% as of today's recent...

SCMP : 10.25 (-2.38%)
Investor Network: Sucampo Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 3, 2017 / Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) will be discussing their earnings results in their Q1 Earnings Call to be held May 3, 2017 at 8:30 AM Eastern Time....

SCMP : 10.25 (-2.38%)
Sucampo Reports First Quarter 2017 Financial Results

Continued Revenue Growth

SCMP : 10.25 (-2.38%)
Sucampo Pharmaceuticals Shares Down 30.8% Since SmarTrend's Sell Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 4 months, Sucampo Pharmaceuticals has returned 30.79% as of today's recent...

SCMP : 10.25 (-2.38%)
Sucampo Announces First Quarter 2017 Earnings Call

Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter 2017 financial results teleconference and webcast at 8:30...

SCMP : 10.25 (-2.38%)
New Study Published in PLOS ONE Advances Science Around VTS-270 for Treatment of Niemann-Pick Disease Type C1

Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the publication of a new study in an independent scientific journal that confirms the unique composition...

SCMP : 10.25 (-2.38%)
Shares of SCMP Down 29.2% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 4 months, Sucampo Pharmaceuticals has returned 29.16% as of today's recent...

SCMP : 10.25 (-2.38%)
Sucampo (SCMP) Down 7.6% Since Earnings Report: Can It Rebound?

Sucampo (SCMP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SCMP : 10.25 (-2.38%)
Drug Makers Stocks Under Scanner -- Synergy Pharma, Novo Nordisk, Apricus Biosciences, and Sucampo Pharma

Stock-Callers.com has issued research reports on four Drug Manufacturers stocks, which are: Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), Novo Nordisk A/S (NYSE: NVO), Apricus Biosciences Inc. (NASDAQ:...

SCMP : 10.25 (-2.38%)
NVO : 41.68 (-0.43%)
APRI : 0.95 (-1.04%)
SGYP : 3.48 (-5.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Sucampo Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Sucampo is focused on developing prostones...

See More

Support & Resistance

2nd Resistance Point 10.48
1st Resistance Point 10.37
Last Price 10.25
1st Support Level 10.17
2nd Support Level 10.08

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.